[ad_1]
NEO Battery Supplies Ltd introduced that it has signed a Memorandum of Understanding (MOU) with an Asia-based producer (the Recycler) of high-purity silicon powder via recycling silicon by-product waste from photo voltaic photovoltaic cell and semiconductor manufacturing.
The electrical car (EV) lithium-ion battery supplies developer stated the aim of the MOU is to considerably improve the worth competitiveness of silicon anode supplies for electrical car lithium-ion batteries by integrating the Recycler’s cost-reduced, recycled silicon enter into NEO’s proprietary silicon anode supplies, NBMSiDE.
Outlook Therapeutics Inc (NASDAQ:OTLK) has introduced monetary outcomes for its fiscal yr ended September 30 and laid out plans for 2023 in an end-of-year letter.
“Our fiscal yr 2022 laid a strong basis for what we imagine might be a transformational 2023,” CEO Russell Trenary III stated. “We’re driving our commercialization planning in the direction of anticipated launch with the accepted FDA submitting of our BLA for ONS-5010 and PDUFA date set for August 29, 2023, and overview of our MAA within the EU underway with a choice date anticipated in early 2024.”
BioHarvest Sciences Inc printed a year-end letter to shareholders, highlighting its 2022 manufacturing will increase and issuing vital income projections for 2023.
“2022 noticed us construct foundational capabilities which have already confirmed to be extremely impactful,” CEO Ilan Sobel stated within the letter to shareholders.
Platinex Inc. (CSE:PTX) stated it has closed the beforehand introduced choice settlement via which it has the best to accumulate a 100% curiosity within the Muskrat Dam vital minerals mission in northwestern Ontario.
The Toronto-based firm stated Muskrat Dam is 125 kilometers (km) northeast of Frontier Lithium’s PAK lithium mission and 125 km northwest of Newmont’s Musselwhite gold mine.
Hillcrest Energy Technologies Ltd (CSE:HEAT, OTCQB:HLRTF) has introduced the closing of the e-book for its beforehand introduced non-brokered non-public placement of models of the corporate with gross proceeds of the providing anticipated to whole $1.518 million.
The corporate anticipates distributing 12,650,000 models at a value of C$0.12 every, ensuing within the anticipated issuance of 14,700,000 shares.
The unique phrases of the providing consisted of as much as 20,000,000 models of the corporate at a value of C$0.12 per unit. Every unit comprises 1.2 widespread shares within the capital of the corporate.
Doubleview Gold Corp (TSX-V:DBG, OTCQB:DBLVF) stated it has closed the second and remaining tranche of its non-brokered flow-through non-public placement for gross proceeds of $170,050.30.
Mixed with the earlier tranche, as introduced on December 16, 2022, the corporate has raised a complete of $1,515,049.90 in flow-through funds.
Tocvan Ventures Corp. (CSE:TOC) has launched its 2022 annual abstract, having achieved a “standout yr” regardless of the difficulties confronted by useful resource firms.
“2022 was a difficult yr for a lot of useful resource firms,” CEO Brodie Sutherland stated in a press release. “Amid the turbulent world markets, Tocvan is proud to have made 2022 one among its most efficient years when it comes to the development of each of our tasks in Sonora and setting the corporate up for a return of investor sentiment in the direction of the dear metals.”
KULR Technology Group Inc (NYSE:KULR) has introduced a partnership with Idea Racing, a number one World Cup Enduro racing crew.
The partnership with Idea comes on the heels of the corporate saying that it’s going to introduce its all-new modular vitality storage platform, KULR ONE, at CES 2023 this January 5-8. KULR ONE is a household of next-generation battery packs bringing a mixture of security, efficiency, intelligence, modularity and reliability to the world’s most demanding purposes.
ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) has posted monetary outcomes for its fiscal third quarter which confirmed that it’s pursuing gross sales of medical-grade chitosan as a brand new near-term business income initiative.
In the course of the 3Q of its fiscal yr ended October 31, 2022, the Montreal-based clinical-stage regenerative medication firm introduced its determination to pursue gross sales of chitosan after finishing an inner business and regulatory readiness course of.
Bridgeline Digital Inc (NASDAQ:BLIN) has introduced that its prescriptive advertising dashboard, eCommerce360, is now obtainable throughout the app retailer on the Shopify platform.
Shopify has partnered with Bridgeline to energy analytics and prescribe new income methods for its base of greater than 4 million customers throughout 175 international locations. Customers now can combine the Bridgeline eCommerce360 (e360) app to their Shopify websites and use the e360 dashboard instantly throughout the Shopify admin interface.
The Good Shroom Co. Inc (TSX-V:MUSH) has disclosed its monetary outcomes for the primary quarter ended October 31, 2022, wherein the corporate recorded $822,569 in gross sales income, over 16 instances development quarter over quarter.
At current, the corporate’s hashish gross sales are primarily in Quebec; nonetheless, it stated it’s anticipated to achieve extra Canadian market share. Product submissions have been made to the governments of Alberta, Nova Scotia and Newfoundland. Its mushroom beverage model, Teonan, continues rising and is now offered in over 250 grocery shops in the US and Canada plus its on-line retailer, the corporate added.
Looking Glass Labs Ltd (LGL) has introduced that its wholly-owned subsidiary, Home of Kibaa (HoK) has considerably superior the event of its Pocket Dimension metaverse providing.
Via the upcoming achievement of quite a few avatar-based and architecture-related milestones, the corporate stated it expects to set a brand new customary for the metaverse business.
Delivra Well being Manufacturers Inc stated its wholly-owned subsidiary, United Greeneries Holdings Ltd., has offered and transferred the title of its Fortunate Lake facility in Saskatchewan efficient as of December 28, 2022, to a 3rd social gathering in Saskatchewan for whole mixture consideration of $3 million. Gord Davey, president and chief govt officer of Delivra Well being, commented: “This transaction instantly strengthens our place within the market by offering working capital to additional develop our main manufacturers Dream Water and LivRelief. The corporate will use the proceeds of this transaction to broaden distribution, model consciousness, innovation and advertising initiatives to speed up the expansion and profitability of the corporate.”
Gold Useful resource Company has introduced that its wholly-owned oblique subsidiary Aquila Assets USA Inc has obtained 12,250,000 widespread shares of Inexperienced Gentle Metals Inc. The shares had been issued upon the conversion at maturity of a non-interest-bearing promissory be aware of Inexperienced Gentle within the principal quantity of C$4.9 million dated October 4, 2021, as amended. The shares had been issued on December 28, 2022, at a conversion value of C$0.40 per share, and symbolize roughly 28.51% of the issued and excellent shares of Inexperienced Gentle. The Inexperienced Gentle be aware was issued to Aquila USA in partial consideration for the C$7.0 million sale by Aquila USA to Inexperienced Gentle of a 100% curiosity in Aquila USA’s Bend and Reef exploration belongings positioned within the State of Wisconsin, which was accomplished on October 4, 2021. On the time of such sale, the guardian firm of Aquila USA was Aquila Assets Inc, which was subsequently acquired by the corporate on December 10, 2021. Previous to the conversion of the Inexperienced Gentle be aware, the corporate didn’t personal or train management or course over any Inexperienced Gentle shares.
BioVie Inc might be featured in an interview on The RedChip Cash Report on Bloomberg TV, this Saturday, December 31, at 7.00pm Japanese Time (ET). Within the unique RedChip Cash Report interview, BioVie’s CEO Cuong Do discusses the corporate’s constructive knowledge from its Part 2 Alzheimer’s and Parkinson’s trials, cognition and motor management outcomes from the trials, the potential to file for US Meals & Drug Administration (FDA) approval in 2024, and way more. events can entry the interview through the next hyperlink: https://www.biviinfo.com/interview_access
[ad_2]
Source link
